Results 241 to 250 of about 109,169 (264)

Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting

Circulation, 2012
Fausto Castriota, Pascal Vranckx, Jlenia Marchesini   +2 more
exaly  

Safety of Short-Term Discontinuation of Antiplatelet Therapy in Patients With Drug-Eluting Stents

Circulation, 2009
KRISTIAN Filion
exaly  

Targeting 12-Lipoxygenase as a Potential Novel Antiplatelet Therapy

Trends in Pharmacological Sciences, 2017
Michael Holinstat
exaly  

Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma

Cancers, 2020
Masaru Harada, Tsuguru Hayashi, Shinji Oe   +2 more
exaly  

Bioactive peptides and proteins as alternative antiplatelet drugs

Medicinal Research Reviews, 2019
Kannan Rr Rengasamy, Seyed Mohammad Nabavi, Haroon Khan   +2 more
exaly  

Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone

Bioresource Technology, 2006
Hoi-Seon Lee
exaly  

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

Lancet, The, 2007
Lelia Duley, Lisa Askie, Lesley A Stewart   +2 more
exaly  

Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

Circulation, 2013
Xinyi Leng, , Yongjun Wang
exaly  

Oral Antiplatelet Therapy

JAMA, 2005
Richard A, Bernstein, Gregory W, Albers
openaire   +2 more sources

Background, Incidence, and Predictors of Antiplatelet Therapy Discontinuation During the First Year After Drug-Eluting Stent Implantation

Circulation, 2010
Salvatore Brugaletta, Victoria Martin Yuste, Juan Casanova   +2 more
exaly